Prescription Patterns for Bipolar Disorder in Asian Countries: Findings from Research on Asian Prescription Pattern-Bipolar Disorder
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objective: Pharmacotherapy including mood stabilizers and antipsychotics are frequently used in bipolar disorder (BD); however, the lack of consensus regarding the definition of polypharmacy hinders conducting comparative studies across different settings and countries. Research on Asian Prescription Pattern (REAP) is the largest and the longest lasting international collaborative research in psychiatry in Asia. The objective of REAP BD was to investigate the prescription patterns of psychotropic medications across Asian countries. The rates of polypharmacy and psychotropic drug load were also analyzed. Methods: The data collection was web-based. Prescription patterns were categorized as (1) mood stabilizer monotherapy: one mood stabilizer; (2) antipsychotic monotherapy: one antipsychotic; (3) simple polypharmacy: one mood stabilizer and one antipsychotic; and (4) complex polypharmacy: ≥ 2 mood stabilizers or/and antipsychotics. The psychotropic drug load in each patient was calculated using the defined daily dose method. Results: Among 2003 patients with BD (52.1% female, 42.4 years) from 12 countries, 1,619 (80.8%) patients received mood stabilizers, 1,644 (82.14%) received antipsychotics, and 424 (21.2%) received antidepressants, with 14.7% mood stabilizer monotherapy, 13.4% antipsychotic monotherapy, 48.9% simple polypharmacy, 20.3% complex polypharmacy, and 2.6% other therapy. The average psychotropic drug load was 2.05 ± 1.40. Results varied widely between countries. Conclusion: Over 70% of psychotropic regimens involved polypharmacy, which accords with the high prevalence of polypharmacy in BD under a permissive criterion (2 or more core psychotropic drugs) worldwide. Notably, ≥ 80% of our sample received antipsychotics, which may indicate an increasing trend in antipsychotic use for BD treatment.
Abstract
Objective: Pharmacotherapy including mood stabilizers and antipsychotics are frequently used in bipolar disorder (BD); however, the lack of consensus regarding the definition of polypharmacy hinders conducting comparative studies across different settings and countries. Research on Asian Prescription Pattern (REAP) is the largest and the longest lasting international collaborative research in psychiatry in Asia. The objective of REAP BD was to investigate the prescription patterns of psychotropic medications across Asian countries. The rates of polypharmacy and psychotropic drug load were also analyzed. Methods: The data collection was web-based. Prescription patterns were categorized as (1) mood stabilizer monotherapy: one mood stabilizer; (2) antipsychotic monotherapy: one antipsychotic; (3) simple polypharmacy: one mood stabilizer and one antipsychotic; and (4) complex polypharmacy: ≥ 2 mood stabilizers or/and antipsychotics. The psychotropic drug load in each patient was calculated using the defined daily dose method. Results: Among 2003 patients with BD (52.1% female, 42.4 years) from 12 countries, 1,619 (80.8%) patients received mood stabilizers, 1,644 (82.14%) received antipsychotics, and 424 (21.2%) received antidepressants, with 14.7% mood stabilizer monotherapy, 13.4% antipsychotic monotherapy, 48.9% simple polypharmacy, 20.3% complex polypharmacy, and 2.6% other therapy. The average psychotropic drug load was 2.05 ± 1.40. Results varied widely between countries. Conclusion: Over 70% of psychotropic regimens involved polypharmacy, which accords with the high prevalence of polypharmacy in BD under a permissive criterion (2 or more core psychotropic drugs) worldwide. Notably, ≥ 80% of our sample received antipsychotics, which may indicate an increasing trend in antipsychotic use for BD treatment.
참고문헌 (32)
- Fornaro M, "Atypical antipsychotics in the treatment of acute bipolar depression with mixed features : a systematic review and exploratory meta-analysis of placebo-controlled clinical trials", Int J Mol Sci, 17, pp.241~ (2016)
- Muneer A, "The treatment of adult bipolar disorder with aripiprazole : a systematic review", Cureus, 8, pp.e562~ (2016)
- Kishi T, "Long-acting injectable antipsychotics for prevention of relapse in bipolar disorder : a systematic review and meta-analyses of randomized controlled trials", Int J Neuropsychopharmacol, 19, pp.pyw038~ (2016)
- Lehman AF, "Practice guideline for the treatment of patients with schizophrenia, second edition", Am J Psychiatry, 161(2 Suppl), pp.1~56 (2004)
- Parks JJ, "Implementing practice guidelines: lessons from public mental health settings", J Clin Psychiatry, 68(Suppl 4), pp.45~48 (2007)
- Daumit GL, "Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and whites in the United States", Arch Gen Psychiatry, 60, pp.121~128 (2003)
- Chong MY, "Antipsychotic drug prescription for schizophrenia in East Asia : rationale for change", Psychiatry Clin Neurosci, 58, pp.61~67 (2004)
- Galling B, "Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and metaregression analysis", World Psychiatry, 16, pp.77~89 (2017)
- Lin SK, "Antipsychotic polypharmacy : a dirty little secret or a fashion?", Int J Neuropsychopharmacol, 23, pp.125~131 (2020)
- Fornaro M, "Prevalence and clinical features associated with bipolar disorder polypharmacy : a systematic review", Neuropsychiatr Dis Treat, 12, pp.719~735 (2016)
- Davis JM, "Dose equivalence of the antipsychotic drugs", J Psychiatr Res, 11, pp.65~69 (1974)
- Leucht S, "Dose equivalents for second-generation antipsychotics : the minimum effective dose method", Schizophr Bull, 40, pp.314~326 (2014)
- "WHO Collaborating centre for drug statistics and methodology" (2017)[URL]
- Hayes J, "Prescribing trends in bipolar disorder : cohort study in the United Kingdom THIN primary care database 1995-2009", PLoS One, 6, pp.e28725~ (2011)
- Olfson M, "National trends in the office-based treatment of children, adolescents, and adults with antipsychotics", Arch Gen Psychiatry, 69, pp.1247~1256 (2012)
- Lähteenvuo M, "Real-world effectiveness of pharmacologic treatments for the prevention of rehospitalization in a Finnish nationwide cohort of patients with bipolar disorder", JAMA Psychiatry, 75, pp.347~355 (2018)
- Grunze H, "The World Federation of Societies of Biological Psychiatry(WFSBP)guidelines for the biological treatment of bipolar disorders : update 2012 on the long-term treatment of bipolar disorder", World J Biol Psychiatry, 14, pp.154~219 (2013)
- Fountoulakis KN, "The International College of Neuro-Psychopharmacology(CINP)treatment guidelines for bipolar disorder in adults(CINP-BD-2017), part 3 : the clinical guidelines", Int J Neuropsychopharmacol, 20, pp.180~195 (2017)
- Yatham LN, "Canadian Network for Mood and Anxiety Treatments(CANMAT)and International Society for Bipolar Disorders(ISBD)2018 guidelines for the management of patients with bipolar disorder", Bipolar Disord, 20, pp.97~170 (2018)
- Correll CU, "One-year incidence rates of tardive dyskinesia in children and adolescents treated with second-generation antipsychotics : a systematic review", J Child Adolesc Psychopharmacol, 17, pp.647~656 (2007)
- Gao K, "Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia : a systematic review", J Clin Psychopharmacol, 28, pp.203~209 (2008)
- Mojtabai R, "National trends in psychotherapy by office-based psychiatrists", Arch Gen Psychiatry, 65, pp.962~970 (2008)
- Olfson M, "National trends in outpatient psychotherapy", Am J Psychiatry, 167, pp.1456~1463 (2010)
- Goldberg JF, "Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder : findings from the STEP-BD", J Clin Psychiatry, 70, pp.155~162 (2009)
- Fung VC, "Complex polypharmacy in bipolar disorder : side effect burden, adherence, and response predictors", J Affect Disord, 257, pp.17~22 (2019)
- Jaracz J, "The pattern of pharmacological treatment of bipolar patients discharged from psychiatric units in Poland", Pharmacol Rep, 70, pp.694~698 (2018)
- Kendall T, "Assessment and management of bipolar disorder : summary of updated NICE guidance", BMJ, 349, pp.g5673~ (2014)
- Lyall LM, "Changes in prescribing for bipolar disorder between 2009 and 2016 : national-level data linkage study in Scotland", Br J Psychiatry, 215, pp.415~421 (2019)
- Haeberle A, "Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP", BMC Psychiatry, 12, pp.153~ (2012)
- Weinstock LM, "Medication burden in bipolar disorder : a chart review of patients at psychiatric hospital admission", Psychiatry Res, 216, pp.24~30 (2014)
- Yang SY, "Polypharmacy and psychotropic drug loading in patients with schizophrenia in Asian countries : fourth survey of Research on Asian Prescription Patterns on antipsychotics", Psychiatry Clin Neurosci, 72, pp.572~579 (2018)
- Tondo L, "Depression and mania in bipolar disorder", Curr Neuropharmacol, 15, pp.353~358 (2017)